Clinical Trial Update: Bioequivalence Study of PMR Compared to Cilostazol IR Tablets in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence trial comparing PMR to Cilostazol IR tablets in healthy volunteers was terminated. The study related to intermittent claudication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Artery Disease

Drugs mentioned

• Cilostazol IR tablets (cilostazol)
• PMR

Snippet

Sponsor: Genovate Biotechnology Co., Ltd., | Conditions: Intermittent Claudication | Phase 1 | Status: TERMINATED